Mi-2 beta (Mi2-β), also known as CHD4, is part of the nucleosome remodeling and deacetylase (NuRD) complex, which plays a role in chromatin remodeling and transcriptional regulation. A class of compounds called Mi2-β activators would include molecules that can enhance the activity of this chromatin remodeler. Discovering activators for Mi2-β would typically require the development of an assay that can accurately measure the chromatin remodeling activity of the NuRD complex. Such an assay could involve using nucleosomes or chromatin substrates that are labeled with fluorescent markers, which would change in fluorescence intensity or resonance upon remodeling by the NuRD complex. High-throughput screening (HTS) platforms could then be employed to test a diverse library of small molecules for their ability to increase the rate or extent of chromatin remodeling by Mi2-β.
Upon identifying potential Mi2-β activators through HTS, the next steps would involve confirming and characterizing the activity of these compounds. Secondary assays would be used to rule out nonspecific effects and to ensure that the observed increase in remodeling activity is directly due to the action of the compounds on Mi2-β. Techniques such as isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) would be invaluable in this phase, as they can provide detailed insights into the binding interactions between the activators and Mi2-β, including information on binding affinity, kinetics, and thermodynamics. These biophysical methods can confirm the direct interaction of activators with Mi2-β and may also reveal whether the activation is competitive or non-competitive with respect to the nucleosome substrate.
Items 41 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|